Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors


    PHARMACEUTICALS 2011 - Establishing Global Drug Substance and Drug Product Specifications ? What the Guidelines Don’t Tell You - Pharmaceuticals webinar By ComplianceOnline

    View: 709

    Website http://complianceonline.com/ecommerce/control/trainingFocus/~product_id=701842?channel=ourglocal | Want to Edit it Edit Freely

    Category Pharmaceuticals,conference,event,Webinar

    Deadline: January 13, 2011 | Date: January 13, 2011

    Venue/Country: Palo Alto, U.S.A

    Updated: 2010-12-03 20:02:43 (GMT+9)

    Call For Papers - CFP

    Learn how to establish global drug substance and drug product specifications that are appropriate to the phase of clinical development and market application, and understand the types of data that are needed to support these specifications.

    Areas Covered in the Seminar:

    ICH guidelines and other relevant sources for setting specifications.

    Recent changes in compendial requirements.

    Minimum requirements for drug substances from Phase 1 through market application.

    Minimum requirement for drug products from Phase 1 through market application.

    Specifications specific to various types of dosage forms.

    Regional differences in specifications.

    Data requirements for setting meaningful acceptance criteria.

    ICH thresholds.

    Impurity qualification.

    Potential pitfalls due to insufficient or inappropriate specifications.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.